Sir Harpal Kumar | |
---|---|
Born | Harpal Singh Kumar 1965 (age 58–59) |
Nationality | British |
Alma mater | St John's College, Cambridge Harvard Business School |
Sir Harpal Singh Kumar (born 1965) is a British medical researcher of Indian descent who had served as the chief executive officer of Cancer Research UK[1][2][3] from April 2008 until June 2018,[4] when he became Senior Vice President and Head of Innovation EMEA at Johnson & Johnson. He left the company in April 2020 and now serves as President of GRAIL Europe.[5][6]